Abstract:e23123 Background: Pleural carcinosis caused by tumors of the chest (e.g., lung and breast cancer) or elsewhere in the body (e.g., ovarian carcinoma) that metastasize to the visceral and/or parietal pleura. Recurrent malignant pleural effusion due to pleural carcinosis is one of the most common findings in oncology. The aim of the study was to identify a miRNA signature associated with clinicians’ prescription of patients with MPE. Methods: We used qRT-PCR assay to evaluate a wide range miRNAs (1920 miRNAs) signature measured from pleural effusion between patients with cancer and healthy controls. From the data of our previous studies we selected a panel of 96 miRNAs related to malignant pleural effusion. Data were compared by three classification methods software for statistics and modeling. We used a first set of 77 pleural effusion samples as training group, including 27 patients affected by Lung Adenocarcinomas (LAC), 9 with other lung cancer, 17 with other tumors and 24 inflammatory patients as negative controls. Moreover, we used more 64 pleural effusion samples for double-blind predictive study. Data analysis was performed using a machine learning approach of a Support Vector Machine classifier with a Student's t-test feature selection procedure. Results: We identified a panel of ten miRNAs with optimum classification performance. The combination of these 10-miRNAs alone could discriminate MPE cases from negative controls with an AUC of 0.969 (accuracy = 93.5%; specificity = 91.7%). The selected panel of another 10-miRNAs could separate lung cancer cases from negative controls with an AUC of 0.973 (accuracy = 94.8%; specificity = 95.8%), and a small panel of 4-miRNAs could good discriminate LAC cases from negative controls with an AUC of 0.946 (accuracy 88.9%; specificity = 100%). The accuracy rate of the double-blind predictive sensitivity value was 90.9% and specificity value was 95.8% for MPE patients with lung cancer of miRNA signature. Conclusions: Our miRNAs profile may serve as a new biomarker for MPE diagnosis. Otherwise, we identified a 10-miRNAs signature for MPE patients with lung cancer and a 4-miRNAs for MPE patients with lung adenocarcinoma.

The Value of MAGE-3 mRNA Expression in Pleural Effusion in Differential Diagnosis of Benign and Malignant Pleural Effusion

Mrna Expression of MAGE Genes in Benign and Malignant Pleural Effusion

Diagnostic Value of Reverse-Transcriptase Polymerase Chain Reaction for MAGE Families Expression in Malignant Thoracic Pleural Effusions

Differential Proteome Profiling of Pleural Effusions from Lung Cancer and Benign Inflammatory Disease Patients

The expression levels of VEGF and ICAM-1 in pleural effusion

The Diagnostic Significance of the Detection of Cytokeratin 19 Mrna by Quantitative RT-PCR in Benign and Malignant Pleural Effusions

Combined Detection of Carcinoembryonic Antigen and C-reactive Protein in Identifying Benign and Malignant Pleural Effusion

Genome-wide Microrna Expression Profiling in Malignant Pleural Effusion to Identify a Ten-Microrna Signature.

Different expression of FoxM1 in human benign and malignant pleural effusion

Value of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in the Differential Diagnosis of Benign and Malignant Pleural Effusion

[Mrna Expressions of MAGE Genes in Human Lung Cancer].

Application of Three Tumor Markers United Detection in Differentiating Benign and Malignant Pleural Effusion

Evaluation of MAGE-1 and MAGE-3 As Tumour-Specific Markers to Detect Blood Dissemination of Hepatocellular Carcinoma Cells.

Clinical Significance of Combined Detection of CEA, CYFRA21-1,CA19-9 and Fer in Differential Diagnosis of Benign Pleural Effusion and Malignant Pleural Effusion

mRNA markers associated with malignant pleural effusion

Mrna of MAGE Genes As Specific Markers in Detection of Tumor Cells in the Peripheral Blood of Patients with Hepatocellular Carcinoma

Diagnostic value of immune-related biomarker FAM83A in differentiating malignant from benign pleural effusion in lung adenocarcinoma

The Diagnostic Value of MCP-1 and RANTES in Tuberculosis and Malignant Pleural Effusion

[Expression of MAGE-1 and MAGE-3 Genes in Gastric Cancer and Gastric Biopsy Tissues and Its Clinical Significance].

Values of immunocytochemical and quantitative morphometric analyses in cytological differential diagnosis of pleural and peritoneal effusion

[Clinical significance of CEA mRNA detection in pleural and peritoneal effusions by real-time fluorescent quantitative RT-PCR].